Updated: January 15, 2026
Why Is Histrelin So Hard to Find? [Explained for 2026]
Author
Peter Daggett

- What Is Histrelin and Why Is It Different From Other Medications?
- Histrelin Is a Specialty Drug — Only Available at Specialty Pharmacies
- What Happened to Vantas (the Prostate Cancer Version)?
- Why Does Insurance Make Histrelin Even Harder to Access?
- Limited Distribution Network Means Fewer Options
- What to Do If You Can't Find Histrelin
- The Bottom Line on Histrelin Availability in 2026
Overview
Histrelin (Supprelin LA) is a specialty drug only available at specialty pharmacies — not your corner drugstore. Here's why it's hard to find and what to do.
Is Histrelin in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Histrelin near you.
If you or your child has been prescribed Histrelin (brand name Supprelin LA), you may already know how challenging it can be to actually get your hands on it. Unlike most medications that sit on a pharmacy shelf waiting to be picked up, Histrelin isn't available at your local CVS, Walgreens, or independent pharmacy. It is a specialty drug that requires a very specific distribution chain — and understanding why can save you a lot of frustration.
What Is Histrelin and Why Is It Different From Other Medications?
Histrelin acetate (Supprelin LA) is a gonadotropin-releasing hormone (GnRH) agonist delivered via a small subcutaneous implant. It is not a pill, a patch, or a standard injection you receive and take home. The 50 mg implant is surgically inserted under the skin of the upper arm by a trained clinician, where it continuously releases medication — about 65 micrograms per day — for up to 12 months. At the end of that period, the implant must be removed and, if continued therapy is needed, a new one inserted.
Because the drug is administered in a doctor's office or clinic — not dispensed by patients themselves at home — it flows through a completely different supply chain than standard retail prescriptions. This is one of the primary reasons Histrelin can be so difficult to track down.
Check live stock now.
Histrelin Is a Specialty Drug — Only Available at Specialty Pharmacies
Supprelin LA is classified as a specialty medication. It is dispensed exclusively through specialty pharmacies, which are pharmacies equipped to handle high-cost, complex medications that require special storage, handling, and coordination of care. The specialty pharmacy ships the implant kit directly to the prescribing physician's office — not to the patient's home.
This means that even if you call every retail pharmacy in your area, none of them will have Histrelin in stock — because they are not authorized or equipped to dispense it. You need to specifically identify specialty pharmacies that carry Supprelin LA and that work with your insurance plan or are willing to process a prior authorization.
What Happened to Vantas (the Prostate Cancer Version)?
Until 2021, Histrelin was sold under two brand names: Supprelin LA (for central precocious puberty in children) and Vantas (for advanced prostate cancer in adults). Endo Pharmaceuticals discontinued Vantas in September 2021 due to manufacturing issues — batches were not meeting quality standards. As of 2026, Vantas is no longer available, and there is no equivalent Histrelin product approved for prostate cancer. Patients who were on Vantas have been transitioned to other androgen deprivation therapies.
For prostate cancer patients, this means Histrelin is simply not an option anymore. If you are searching for Vantas specifically, work with your oncologist or urologist to identify an appropriate alternative.
Why Does Insurance Make Histrelin Even Harder to Access?
Histrelin is extraordinarily expensive. The list price for a single Supprelin LA implant — which lasts 12 months — is approximately $49,000 or more at cash price. For context, private payer reimbursement was approximately $45,291 per unit as of January 2026. Even with insurance, Medicare patients face a 20% co-insurance, which amounts to roughly $7,500 out of pocket for one implant.
Because of this cost, virtually every insurance plan requires prior authorization before they will cover Supprelin LA. Insurers want documentation that the diagnosis is confirmed (usually with pubertal LH/FSH levels), that the prescribing provider has the appropriate specialty, and that the criteria for central precocious puberty are met. This prior authorization process can take days or even weeks — further delaying access to the medication.
Histrelin is typically covered under the medical benefit (not pharmacy benefit) because it is administered in a medical office. This means it is billed under HCPCS J-code J9226, not as a standard pharmacy prescription — adding another layer of complexity for patients and families trying to understand what they owe.
Limited Distribution Network Means Fewer Options
Because Histrelin is a single-source branded product with no generic equivalent, it is only manufactured by Endo Pharmaceuticals. There are no competing manufacturers who might step in during a supply gap. The limited distribution network, combined with strict insurance requirements and the need for physician-office administration, makes each step of the process a potential point of failure.
That's where medfinder can help. medfinder calls specialty pharmacies on your behalf to determine which ones have Histrelin in stock and can fill your prescription — saving you hours of phone calls and confusion.
What to Do If You Can't Find Histrelin
If you are struggling to access Supprelin LA, here are practical steps to take:
Contact the Endo Pharmaceuticals Supprelin LA Support Center at 866-316-7263 — they can help identify specialty pharmacies and navigate insurance issues.
Ask your prescribing physician's office to contact their preferred specialty pharmacy — many pediatric endocrinology practices have established relationships with specific specialty pharmacies.
Inquire about Endo's Patient Assistance Program — patients who qualify may receive the medication at no charge.
If Supprelin LA is unavailable due to supply issues, ask your pediatric endocrinologist about GnRH agonist alternatives like Leuprolide (Lupron Depot-Ped) or Triptorelin (Triptodur) — see our guide on alternatives.
Found
Rate
on average
The Bottom Line on Histrelin Availability in 2026
Histrelin isn't hard to find because of a drug shortage — it's hard to find because it exists entirely outside the normal pharmacy system. It is a specialty drug dispensed through specialty pharmacies, administered in-office, and subject to mandatory prior authorization. Understanding these realities upfront is the first step to navigating the process successfully. For more tactical help, read our guide: How to find Histrelin in stock near you.
Frequently Asked Questions
Histrelin (Supprelin LA) is a specialty medication that is only dispensed through specialty pharmacies, not retail chains like CVS or Walgreens. The implant is shipped directly to the doctor's office where it is surgically inserted. Retail pharmacies are not authorized or equipped to carry it.
No. Endo Pharmaceuticals discontinued Vantas (histrelin for prostate cancer) in September 2021 due to manufacturing quality issues. As of 2026, Vantas is no longer available. The only histrelin product still on the market is Supprelin LA, which is approved for central precocious puberty in children.
No. There is no FDA-approved generic version of Histrelin (Supprelin LA) as of 2026. It is a single-source branded product manufactured exclusively by Endo Pharmaceuticals. Patients must use the brand-name product, which is why the cost remains very high.
Most insurance plans cover Supprelin LA for central precocious puberty (CPP) with prior authorization. It is billed under the medical benefit using J-code J9226, not as a standard pharmacy claim. Prior authorization requires documentation of a CPP diagnosis, pubertal hormone levels, and often must be prescribed by or in consultation with a pediatric endocrinologist.
The list price for a single Supprelin LA implant is approximately $49,000 or more. Private payer reimbursement was approximately $45,291 per unit as of January 2026. Endo Pharmaceuticals offers a Patient Assistance Program that may provide the medication at no charge to eligible patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Histrelin also looked for:
More about Histrelin
38,224 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





